Cambridge Nucleomics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Angel
- Investors
-
8
Cambridge Nucleomics General Information
Description
Developer of a biotechnology platform designed to enable fast and direct quantification of native RNA molecules. The company's platform digitizes RNA measurement with single-molecule accuracy, providing high-multiplexed, enzyme-free detection that enhances RNA quantification, diagnostics, and drug discovery, enabling pharmaceutical and clinical researchers to achieve precise and scalable insights for personalized medicine.
Contact Information
Website
www.cambridge-nucleomics.comCorporate Office
- Ketton Suite King Centre, Main Road
- Barleythorpe, Oakham
- Rutland LE15 7WD
- England, United Kingdom
Corporate Office
- Ketton Suite King Centre, Main Road
- Barleythorpe, Oakham
- Rutland LE15 7WD
- England, United Kingdom
Cambridge Nucleomics Timeline
Cambridge Nucleomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Angel (individual) | 01-May-2025 | Completed | Generating Revenue | |||
| 8. Grant | 01-Feb-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 27-Apr-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 27-Apr-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 23-Mar-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Sep-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Generating Revenue |
Cambridge Nucleomics Signals
Cambridge Nucleomics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cambridge Angels | Angel Group | Minority | ||
| Trinity Bradfield | Corporation | |||
| Berkeley SkyDeck | Accelerator/Incubator | |||
| Factory Plus | Accelerator/Incubator | Minority | ||
| Cancer Tech Accelerator | Accelerator/Incubator |
Cambridge Nucleomics FAQs
-
When was Cambridge Nucleomics founded?
Cambridge Nucleomics was founded in 2021.
-
Where is Cambridge Nucleomics headquartered?
Cambridge Nucleomics is headquartered in Rutland, United Kingdom.
-
What is the size of Cambridge Nucleomics?
Cambridge Nucleomics has 7 total employees.
-
What industry is Cambridge Nucleomics in?
Cambridge Nucleomics’s primary industry is Other Healthcare Technology Systems.
-
Is Cambridge Nucleomics a private or public company?
Cambridge Nucleomics is a Private company.
-
What is Cambridge Nucleomics’s current revenue?
The current revenue for Cambridge Nucleomics is .
-
How much funding has Cambridge Nucleomics raised over time?
Cambridge Nucleomics has raised $341K.
-
Who are Cambridge Nucleomics’s investors?
Cambridge Angels, Trinity Bradfield, Berkeley SkyDeck, Factory Plus, and Cancer Tech Accelerator are 5 of 8 investors who have invested in Cambridge Nucleomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process